-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

901. Health Services and Quality—Non-Malignant Conditions: Poster III

Symposia: Health Services and Quality—Non-Malignant Conditions Program: Oral and Poster Abstracts
Type: Poster
Monday, December 12, 2022: 6:00 PM-8:00 PM
Hall D (Ernest N. Morial Convention Center)

Chuka Udeze1*, Kristin Evans2*, Yoojung Yang1*, Timothy Lillehaugen2*, Janna Manjelievskaia2*, Urvi Mujumdar1*, Nanxin Li1 and Biree Andemariam, MD3

1Vertex Pharmaceuticals Incorporated, Boston, MA
2Merative, Cambridge, MA
3New England Sickle Cell Institute, University of Connecticut Health, Farmington, CT

Patricia Locantore-Ford, MD1, Joanne Elaine Pechar, MSN, ANP-BC, AGACNP-BC2*, Douglas William Ford3*, J. Shawn Miles, MD4* and Frederick Nunes, MD5*

1Abramson Cancer Center, Pennsylvania Hospital of the University of Pennsylvania, Philadelphia, PA
2Department of Penn Orthopedics, Pennsylvania Hospital/Penn Medicine, Philadelphia, PA
3SC Johnson College of Business, Cornell University, Ithaca, NY
4Department of Cardiology, Pennsylvania Hospital at University of Pennsylvania, Philadelphia
5Gastroenterology Pennsylvania Hospital, Pennsylvania Hospital at University of Pennsylvania, Philadelphia

Jeffrey A. Gilreath, PharmD1,2, Isa Tali, Rn3*, Kim Ashbaker, Rn3*, Kara Fialkowski, NP3*, George M. Rodgers, MD, PhD4,5, Ming Yeong Lim, MBBChir6, Shawn Newton, CPhT3* and Jacob Murrill, BS Pharm, MS3*

1Department of Pharmacy, Huntsman Cancer Institute/University of Utah, Salt Lake City, UT
2Department of Pharmacotherapy, University of Utah, Salt Lake City, UT
3Utah Center for Bleeding & Clotting Disorders at the University of Utah, University of Utah, Salt Lake City, UT
4Univ. of Utah Medical Center, Salt Lake City, UT
5Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake City, UT
6Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT

Ashima Singh, PhD, MS1, Mahua Dasgupta1*, Amanda M. Brandow, DO, MS1 and David C Brousseau, MD, MS2

1Medical College of Wisconsin, Milwaukee, WI
2Children's Hospital of Wisconsin Children's Corporate Center, Milwaukee, WI

Gabriela Sanz-Linares, MD1*, Alberto Mussetti2,3*, Adaia Albasanz-Puig4*, Iñaki Salvador-Corre5*, Anna Sureda6, Carlota Gudiol4*, Ramon Salazar7*, Mar Marin7*, Margarita García Martín8*, Valentin Navarro9*, Irma De la Haba10*, Eva Coma10*, Xavier Dura4*, Sandra Fontanals11*, Gala Serrano12*, Claudia Cruz13*, Rafael Mañez14* and Gabriel Moreno-González15*

1HEMATOLOGY, INSTITUT CATALA D'ONCOLOGIA, BARCELONA, Spain
2Department of Hematology, Hospital Duran i Reynals, Instituto Catalán de Oncología, L'Hospitalet De Llobregat, Barcelona, Spain
3Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), L'Hospitalet De Llobregat, Barcelona, Spain
4Infectious Disease Department, Hospital Universitari de Bellvitge, Barcelona, Spain
5Immunology Department, Hospital Universitari de Bellvitge, Barcelona, Spain
6Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL); Biomedical Research Institute, Universitat de Barcelona, Barcelona, Spain
7Oncology Department, Hospital Universitari de Bellvitge, Barcelona, Spain
8Clinical Trials Unit, Institut Català d'Oncologia, Barcelona, Spain
9Clinical Trials Units, Institut Català d'Oncologia, Barcelona, Spain
10Oncology Emergency Unit, Institut Català d'Oncologia, Barcelona, Spain
11Pharmacology Department, Institut Català d'Oncologia, Barcelona, Spain
12Palliative Care Department, Institut Català d'Oncologia, barce, Spain
13Palliative Care Department, Institut Català d'Oncologia, Barcelona, Spain
14Intensive Care Department, Hospital Universitari de Bellvitge, Barcelona, Spain
15Intensive Care Department, Hospital Universitari de Bellvitge, barcelona, Spain

Christine L Kempton, MD, MSc1, Stacey Fedewa, PhD, MPH2* and Amanda B Payne, PhD, MPH3

1Hemophilia of Georgia Center for Bleeding & Clotting Disorders of Emory, Emory University, Atlanta, GA
2Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
3Centers for Disease Control and Prevention, Atlanta, GA

Anne K Hubben, MD1, Dana E. Angelini, MD2 and Sandra Mazzoni, DO2*

1Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
2Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic Foundation, Cleveland, OH

Steven J. Hardy, PhD1,2, Megan E. Connolly, PhD1,2*, Sydney M. Forman, BS2* and Robert Sheppard Nickel, MD, MSc3,4

1Departments of Psychiatry & Behavioral Sciences and Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC
2Division of Hematology, Children's National Hospital, Washington, DC
3George Washington University School of Medicine and Health Sciences, Washington, DC
4Children's National Hospital, Washington, DC

Samuel Misiani Mbunya, BSc, MBA1,2*, Festus Njuguna, MD1,3*, Carole Kilach, MD1*, Joseph Kipkoech Kirui, BA, MSc1*, Anne Greist, MD2, Anthony Betbadal, MD2, Seethal A Jacob, MD, MS4,5,6, Terry Vik, MD4,6* and Tyler Severance, MD, MEd4,6,7*

1AMPATH/Moi Teaching and Referral Hospital, Eldoret, Kenya
2Indiana Hemophilia and Thrombosis Center, Indianapolis, IN
3Pediatrics, Moi University College of Health Sciences, School of Medicine, Eldoret, Kenya
4Pediatric Hematology/Oncology, Riley Hospital for Children, Indianapolis, IN
5Center for Pediatric and Adolescent Comparative Effectiveness Research, Riley Hospital For Children, Indianapolis, IN
6Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN
7Department of Child Health, University of Missouri, Columbia, MO

Anjali R Oberoi1*, Seethal A Jacob, MD, MS2, Traci M Kazmerski, MD, MS3*, Hannah Fassel, MD4 and Maayan Leroy-Melamed, MD, MPH5*

1Tufts University School of Medicine, Boston, MA
2Pediatric Hematology/Oncology, Riley Hospital for Children, Indianapolis, IN
3Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA
4Hasbro Children's Hospital, Providence, RI
5Tufts Medical Center, Boston, MA

Ronak Mistry, DO1, Ameet Patel, MD, MMHC2 and Benjamin F. Tillman, MD3

1Vanderbilt University Medical Center, Division of Hematology and Oncology, Department of Medicine, Nashville, TN
2Oncology Hematology Care, Cincinnati, OH
3Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN

Connor McLaughlin, MD1*, Katy Loos, CRNP, MSN2*, Geno Merli, MD3* and Ruben Rhoades, MD2

1Department of Medicine, Thomas Jefferson University, Philadelphia, PA
2Division of Hematology, Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA
3Division of Vascular Medicine, Thomas Jefferson University, Philadelphia, PA

Fatima M Khadadah, FRCPC, MBBChir1,2, Wid Yaseen2*, Jane Zhao, MSc3*, Kristine Matusiak, MBBS2, Eden Adejobi4*, Jeffrey Allain4*, Helena Dhamko, MD5*, Zachary Liederman, MD5*, Danielle Buell, MD2*, Andrew Smith, MD6*, Richard Ward, MSc, MRCP, FRCPath7* and Richard Dunbar-Yaffe, MD2*

1Kuwait Cancer Control Centre, Kuwait, Kuwait
2University of Toronto, Toronto, ON, Canada
3Toronto Rehabilitation Institute, University Health Network, Toronto, ON, Canada
4University Health Network, Toronto, ON, Canada
5Toronto General Hospital, University Health Network, Toronto, ON, Canada
6Centre for Addiction and Mental Health, Addiction Medicine Services, Toronto, ON, Canada
7Division of Medical Oncology and Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada

Amanda Okolo, MPH1*, William K. Kronenberger, PhD2*, Chris Roberson, JD, MPH1*, Isaac A. Janson, PhD1*, Mackenzie Nolte, BS3*, Lisa Littner, MPH, MSW, LISW-S, CHES3*, James Okungade, MBBS1* and Amy D. Shapiro, MD1

1Indiana Hemophilia and Thrombosis Center, Indianapolis, IN
2Psychiatry, Indiana University School of Medicine, Indianapolis, IN
3Cancer and Blood Diseases Institute, Department of Hematology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH

Kelsey Uminski, MD1, Iris Perelman, MSc2*, Johnathan Mack, MD, FRCPC2,3* and Alan Tinmouth, MD, FRCPC2,3*

1Division of Hematology, University of Calgary, Calgary, AB, Canada
2Ottawa Hospital Research Institute, Ottawa Hospital Center for Transfusion, Ottawa, ON, Canada
3Division of Hematology, University of Ottawa, Ottawa, ON, Canada

Paul Bernard Lemieux1*, Diletta Maira2*, Natalia Scaramellini, MD1,2*, Margherita Migone De Amicis, MD2*, Valeria Di Stefano1,2*, Marta Ferraresi, MD1,2*, Elena Cassinerio, MD2*, Maria Domenica Domenica Cappellini, MD1, Giovanna Graziadei, MD2* and Irene Motta, MD1,2*

1Università degli Studi di Milano, Milano, Italy
2Rare Diseases Center, General Medicine Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy

Iuliia Kovalenko, MD1, Konstantin Golubykh1*, Martin Cuevas1*, Nadim Ammari2*, Maidah Malik3*, Manpreet Sandhu3*, Hafiz Qurashi4*, Tabinda Saleem4*, Saketram Komanduri3*, Yijin Wert3* and Kit Lu5*

1UPMC Harrisburg, Harrisburg, PA
2Drexel University College of Medicine, Philadelphia, PA
3UPMC Harrisburg, Harrisburg
4UPMC Pittsburg, Pittsburg
5UPMC Hillman Cancer Center, Harrisburg

Christos Papagiannopoulos1*, Marta Salvador Ordoño2* and Elisabete Gonçalves3*

1CTI Clinical Trial and Consulting Services, Stockholm, Sweden
2CTI Clinical Trial and Consulting Services, Madrid, Spain
3CTI Clinical Trial and Consulting Services, Lisbon, Portugal

Muhammad Zain Farooq, MD1, Aruba Sohail, MBBS2*, Areej Fatima, MBBS2*, Areesha Jawed, MBBS2* and Michael Jaglal, MD3

1Hematology/Oncology, Moffitt Cancer Center, Tampa, FL
2Dow University of Health Sciences, Karachi, Pakistan
3Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Brandon Hardesty, MD1, Joel Bowen, BS2*, Suman L Sood, MD3, Craig M. Kessler, MD4, Maissaa Janbain, MD5, Miguel Escobar, MD6* and Doris V. Quon, MD, PhD7

1Indiana Hemophilia and Thrombosis Center, Indianapolis, IN
2Indiana Hemophilia & Thrombosis Center, Indianapolis, IN
3Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor, MI
4Georgetown University Medical Centre, Washington, DC
5Tulane University Health Sciences Center, New Orleans, LA
6Gulf States Hemophilia and Thrombophilia Center, Houston, TX
7Orthopaedic Hemophilia Treatment Center, Los Angeles, CA

Paige Reilly, MD1*, Zahrah Al Khuridah, MBBS2*, Ryan Cooper, BS3*, Lewis L. Hsu, MD, PhD4 and Cristiana Hentea, MD5*

1Pediatric Hematology-Oncology Division, University of Illinois, CHICAGO, IL
2University of Illinois at Chicago, Chicago, IL
3Pediatric Hematology, Sickle Cell Center, University of Illinois at Chicago, Chicago, IL
4Pediatric Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
5Pediatric Hematology Oncology Division, University of Illinois, Chicago, IL

Matthew L Chase, MD1, Reed E. Drews, MD2, Alfred I Lee, MD, PhD3, Erin G Reid, MD, MS4, Aaron T. Gerds, MD, MS5, Gabriela S. Hobbs, MD6, Leslie R Ellis, MD, MSHPEd, FACP7, Marc Stuart Zumberg, MD8, Jonathan Berry, MD1 and Jason A Freed, MD9

1Divisions of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, MA
2Division of Hematology and Hematological Malignancies, Beth Israel Deaconess Medical Center, Boston, MA
3Classical Hematology, Section of Hematology, Yale University School of Medicine, New Haven, CT
4Moores Cancer Center, University of California, San Diego, La Jolla, CA
5Department of Hematology and Medical Oncology,, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
6Cancer Center, Massachusetts General Hospital, Boston, MA
7Atrium Health Wake Forest Baptist, Winston Salem, NC
8Division of Hematology/Oncology, University of Florida, Gainesville, Gainesville, FL
9Division of Hematology and Hematological Malignancies, Beth Israel Deaconess, Boston, MA

Jonathan G. Bardahl, DO1, Monica I. Ardura, DO, MSCS2* and Jennifer A. Rothman, MD1

1Division of Pediatric Hematology-Oncology, Duke University Medical Center, Durham, NC
2Division of Pediatric Infectious Diseases & Host Defense Program, Nationwide Children's Hospital, Columbus, OH

Abi Vijenthira, MD1,2, Andrew S Wilton, MSc3*, Grace H Tang, MSc4,5*, Tara Gomes, PhD, MHSc6,7* and Michelle Sholzberg, MDCM, MSc8,9,10

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
2Department of Medicine, University of Toronto, Toronto, ON, Canada
3Institute of Clinical Evaluative Sciences, Toronto, Canada
4Institute of Health Policy Management and Evaluation, University of Toronto, Toronto, ON, Canada
5St Michael's Hospital, University of Toronto, Toronto, ON, Canada
6Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
7Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada
8Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, ON, Canada
9Hematology, St. Michael's Hospital, Toronto, ON, Canada
10Medicine, University of Toronto, Toronto, ON, Canada

*signifies non-member of ASH